Barely Significant
← all excerpts

Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC.

Biomark Res · 2025 · PMC12750570 · PMID 41291854

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Blood biochemistry results were within the normal range, except for a transient and reversible increase in aspartate aminotransferase and alanine aminotransferase levels in one animal from each dosing group, which occurred three days after the first dose and showed a trend towards recovery by day 7 (Supplemental Figure 7 G–L).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.